Literature DB >> 22505439

OXA-type carbapenemases in Acinetobacter baumannii in South America.

Andrés Opazo1, Mariana Domínguez, Helia Bello, Sebastian G B Amyes, Gerardo González-Rocha.   

Abstract

Acinetobacter baumannii is an opportunistic pathogen that is frequently involved in outbreaks of infection, occurring mostly in intensive care units. The increasing incidence of carbapenem resistance in A. baumannii worldwide is a concern since it limits drastically the range of therapeutic alternatives. The most important mechanism of carbapenem resistance is the enzymatic hydrolysis mediated by carbapenemases. In A. baumannii these enzymes are usually OXA-type carbapenemases, and belong to class D according to the classification of Ambler. The OXA-type carbapenemases are divided into five subgroups, four of which correspond to acquired carbapenemases, which accounts for the distribution of genes blaOXA in different geographic areas. In this work we review the different types of OXA-type carbapenemases present in A. baumannii, emphasizing the current situation in South America with special mention to the findings in Chile.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22505439     DOI: 10.3855/jidc.2310

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  17 in total

1.  Characterization of the First OXA-10 Natural Variant with Increased Carbapenemase Activity.

Authors:  Stathis D Kotsakis; Carl-Fredrik Flach; Mohammad Razavi; D G Joakim Larsson
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

Review 2.  The spread of carbapenemase-producing bacteria in Africa: a systematic review.

Authors:  Rendani I Manenzhe; Heather J Zar; Mark P Nicol; Mamadou Kaba
Journal:  J Antimicrob Chemother       Date:  2014-09-26       Impact factor: 5.790

3.  Association of blaOXA-23 and bap with the persistence of Acinetobacter baumannii within a major healthcare system.

Authors:  Ting L Luo; Alexander H Rickard; Usha Srinivasan; Keith S Kaye; Betsy Foxman
Journal:  Front Microbiol       Date:  2015-03-12       Impact factor: 5.640

4.  Nosocomial Acinetobacter baumannii Infections and Changing Antibiotic Resistance.

Authors:  Ismail Necati Hakyemez; Abdulkadir Kucukbayrak; Tekin Tas; Aslihan Burcu Yikilgan; Akcan Akkaya; Aliye Yasayacak; Hayrettin Akdeniz
Journal:  Pak J Med Sci       Date:  2013-09       Impact factor: 1.088

5.  Effect of Efflux Pump Inhibitor Carbonyl Cyanide 3-Chlorophenylhydrazone on the Minimum Inhibitory Concentration of Ciprofloxacin in Acinetobacter baumannii Clinical Isolates.

Authors:  Abdollah Ardebili; Malihe Talebi; Leila Azimi; Abdolaziz Rastegar Lari
Journal:  Jundishapur J Microbiol       Date:  2014-01-01       Impact factor: 0.747

6.  Mutant prevention concentrations of imipenem and meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii.

Authors:  E Dahdouh; S H Shoucair; S E Salem; Z Daoud
Journal:  ScientificWorldJournal       Date:  2014-12-30

7.  Antibiotic Resistance Profile and Distribution of Oxacillinase Genes Among Clinical Isolates of Acinetobacter baumannii in Shiraz Teaching Hospitals, 2012 - 2013.

Authors:  Sara Kooti; Mohammad Motamedifar; Jamal Sarvari
Journal:  Jundishapur J Microbiol       Date:  2015-08-01       Impact factor: 0.747

8.  Crystal structure and kinetic analysis of the class B3 di-zinc metallo-β-lactamase LRA-12 from an Alaskan soil metagenome.

Authors:  María Margarita Rodríguez; Raphaël Herman; Barbara Ghiglione; Frédéric Kerff; Gabriela D'Amico González; Fabrice Bouillenne; Moreno Galleni; Jo Handelsman; Paulette Charlier; Gabriel Gutkind; Eric Sauvage; Pablo Power
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

9.  Escherichia coli Overexpressing a Baeyer-Villiger Monooxygenase from Acinetobacter radioresistens Becomes Resistant to Imipenem.

Authors:  Daniela Minerdi; Ivan Zgrablic; Silvia Castrignanò; Gianluca Catucci; Claudio Medana; Maria Elena Terlizzi; Giorgio Gribaudo; Gianfranco Gilardi; Sheila J Sadeghi
Journal:  Antimicrob Agents Chemother       Date:  2015-10-12       Impact factor: 5.191

10.  Assessment of combination therapy in BALB/c mice injected with carbapenem-resistant Enterobacteriaceae strains.

Authors:  Noor A Salloum; Kohar Annie B Kissoyan; Sukayna Fadlallah; Katia Cheaito; George F Araj; Rima Wakim; Souha Kanj; Zeina Kanafani; Ghassan Dbaibo; Ghassan M Matar
Journal:  Front Microbiol       Date:  2015-09-22       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.